Biomarkers for graft-versus-host disease
US12099068B2 · kind B2 · utility
0Cited by
35References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 2022 |
| Grant date | Sep 24, 2024 |
| Priority date | — |
| Expiry date | Jul 2, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/60
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Biomarkers are provided that are predictive of a subject's responsiveness to a therapy comprising a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing Graft-Versus-Host Disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.